Literature DB >> 9758352

Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML.

J Serrano1, J Román, J A Castillejo, J Sánchez, J A Navarro, C Martín, C Herrera, A Torres.   

Abstract

We report a patient with Ph chromosome-positive CML who underwent an HLA-identical T cell-depleted BMT from a sibling donor. DNA polymorphism analysis showed complete donor chimaerism after BMT, followed by mixed chimaerism of granulocytes, natural killer cells and B lymphocytes, with T lymphocytes host-derived at day +120 post BMT. From month +20 haematopoiesis was exclusively of host origin in all cell lineages. RT-PCR was used in order to detect residual disease, but at the time, analysis did not show BCR-ABL transcripts. This case is unusual in that non-malignant stem cells of recipient origin survived the transplant and reconstituted haematopoiesis after BMT. Two years post transplant, no molecular or haematological relapse was documented. The observation that subsequent recipient recovery without molecular relapse implies that, at least in this case, the GVL effect can occur in the absence of donor T cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758352     DOI: 10.1038/sj.bmt.1701379

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Autologous reconstitution leading to sustained JAK2-V617F negativity post allogeneic hematopoietic stem cell transplant in JAK2-V617F positive myelofibrosis.

Authors:  P Torka; T Hahn; J Bertolo; H Liu; M Ross; P Paplham; A Jankowski; G Deeb; G Chen; P McCarthy
Journal:  Bone Marrow Transplant       Date:  2015-07-27       Impact factor: 5.483

2.  Successful eradication of chronic myeloid leukemia in a child despite allogeneic graft rejection.

Authors:  Susanna Vuorenoja; Kim Vettenranta; Olli Lohi
Journal:  Cancer Rep (Hoboken)       Date:  2022-07-07

3.  Autologous Hematopoietic Recovery after Unrelated Umbilical Cord Blood Transplantation with Myeloablative Conditioning for Acute Myelogenous Leukemia.

Authors:  Ayumi Gomyo; Hideki Nakasone; Hidenori Wada; Shunto Kawamura; Nozomu Yoshino; Junko Takeshita; Kazuki Yoshimura; Yukiko Misaki; Aki Tanihara; Yu Akahoshi; Machiko Kusuda; Masaharu Tamaki; Koji Kawamura; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.